20 results on '"Hutchings, Martin"'
Search Results
2. Functional Imaging
3. Improvements in Imaging of Hodgkin Lymphoma: Positron Emission Tomography.
4. Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement.
5. Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography.
6. 18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.
7. Abstracts from the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.
8. Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.
9. Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma.
10. PET/CT in the management of haematological malignancies.
11. Early interim PET scan in Hodgkin lymphoma: Where do we stand?
12. FDG-PET in the clinical management of Hodgkin lymphoma
13. A small change makes a big difference in Hodgkin lymphoma.
14. New clues to the prognostic challenge of Hodgkin lymphoma.
15. Suspected Richter transformation: positron emission tomography/computed tomography tells us who should have a biopsy and where.
16. The role of bone marrow biopsy in Hodgkin lymphoma staging: 'To be, or not to be, that is the question'?
17. Pre-transplant positron emission tomography/computed tomography (PET/CT) in relapsed Hodgkin lymphoma: time to shift gears for PET-positive patients??
18. Routine follow-up scanning of patients with lymphoma: who, when, how, and why?
19. Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
20. The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.